Jul 28, 2018

Alternative splicing in cardiomyopathy

Biophysical Reviews
A Beqqali


Alternative splicing is an important mechanism used by the cell to generate greater transcriptomic and proteomic diversity from the genome. In the heart, alternative splicing is increasingly being recognised as an important layer of post-transcriptional gene regulation. Driven by rapidly evolving technologies in next-generation sequencing, alternative splicing has emerged as a crucial process governing complex biological processes during cardiac development and disease. The recent identification of several cardiac splice factors, such as RNA-binding motif protein 20 and 24, not only provided important insight into the mechanisms underlying alternative splicing but also revealed how these splicing factors impact functional properties of the heart. Here, we review our current knowledge of alternative splicing in the heart, with a particular focus on the factors controlling cardiac alternative splicing and their role in cardiomyopathies and subsequent heart failure.

  • References
  • Citations1


  • We're still populating references for this paper, please check back later.
  • References
  • Citations1


Mentioned in this Paper

Transcription, Genetic
RBM20 gene
Massively-Parallel Sequencing
Nuclear mRNA Cis Splicing, via Spliceosome
Cardiac Development
RNA Splicing

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Related Papers

Circulation Research
Maarten M G van den HoogenhofEsther E Creemers
Wiley Interdisciplinary Reviews. RNA
Benjamin Cieply, Russ P Carstens
Journal of Cardiovascular Translational Research
Enrique Lara-PezziPablo García-Pavía
© 2020 Meta ULC. All rights reserved